Importance: To date, no dermoscopic features have been described for the diagnosis of primary cutaneous B-cell lymphoma (PCBCL). This tool might be helpful for the clinical differential diagnosis in the context of single erythematous nodules of the skin. Observations: Ten cases of PCBCL, presenting clinically as solitary red/pinkish nodules, were retrospectively retrieved. Patient data were collected along with dermoscopic and histopathological features of each lesion. Most lesions (9/10) showed white circles with a salmon-colored background/area (6 lesions), scales (7 lesions), arborizing vessels (5 lesions) or a polymorphous vascular pattern (2 lesions). Histology revealed a cutaneous marginal zone lymphoma in 6 lesions, a follicle center lymphoma in 2 lesions and a diffuse large B-cell lymphoma in 2 lesions. Conclusions and Relevance: Dermoscopic examination may be helpful for improving the clinical recognition of PCBCL although skin biopsy remains mandatory.

1.
Suárez AL, Pulitzer M, Horwitz S, et al: Primary cutaneous B-cell lymphomas. I. Clinical features, diagnosis, and classification. J Am Acad Dermatol 2013;69:329; quiz 341-342.
2.
Pileri A Jr, Patrizi A, Agostinelli C, et al: Primary cutaneous lymphomas: a reprisal. Semin Diagn Pathol 2011;28:214-233.
3.
Mascolo M, Piccolo V, Iannuzzo G, et al: Primary cutaneous diffuse large B-cell lymphoma with cranial vault and dura mater involvement. J Eur Acad Dermatol Venereol 2014, Epub ahead of print.
4.
Baroni A, Piccolo V: Images in clinical medicine. Red melanoma. N Engl J Med 2013;368:1536.
5.
Moura FN, Thomas L, Balme B, Dalle S: Dermoscopy of lymphomatoid papulosis. Arch Dermatol 2009;145:966-967.
6.
Lallas A, Apalla Z, Lefaki I, et al: Dermoscopy of early stage mycosis fungoides. J Eur Acad Dermatol Venereol 2013;27:617-621.
7.
Fujimura T, Hidaka T, Hashimoto A, Aiba S: Dermoscopy findings of pseudolymphomatous folliculitis. Case Rep Dermatol 2012;4:154-157.
8.
Piccolo V, Mascolo M, Russo T, et al: A solitary fast growing red nodule of the abdomen. J Dtsch Dermatol Ges 2014;12:1147-1148.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.